Catalyst
Slingshot members are tracking this event:
Lilly's (LLY) Lartruvo Approved by FDA by Soft Tissue Sarcoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LLY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Lartruvo, Soft Tissue Sarcoma, Fda, Phase 2, Jgdg, Doxorubicin
